When to seek medical advice: Severe pain, swelling, or signs of infection at injection sites Allergic symptoms (rash, difficulty breathing, facial swelling) Unexplained fatigue, jaundice, or dark urine Any concerning symptoms following injection Patients should always disclose use of lipotropic injections to their GP, as this information may be relevant for diagnosis and management of other conditions
INSR B -IGF1R hybrids comprises up to 30% of INSR and IGF-I receptors in muscle due to high expression of both and this hybrid predominantly responds to IGF-I (less to insulin) and explains the important role of IGF-I in growth and metabolism in skeletal muscle
Yes, both cyanocobalamin and methylcobalamin are used to treat vitamin B12 deficiency
Modified C-terminal Growth Hormone Peptide Molecular Formula: C78H123N23O23S2 Molecular Weight: 1815.1 g/mol CAS Number: 221231-10-3 Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Peptide Classification: Synthetic hGH fragment peptide Peptide Type: Modified C-terminal human growth hormone fragment Purity (HPLC): 99.5% Appearance: White to off-white lyophilised powder Solubility: Soluble in water and buffered aqueous solutions Pack Size: 5mg per vial Form: Lyophilised solid Laboratory Handling & Storage Store unopened vials desiccated at -20C or below, protected from light, to maintain long-term stability of the lyophilised solid
